Cancel
Digistain
See Linkedin
Digistain Employees
10 people indexed:
-
59mvm7m6@fv2x79qlj.15.q5 Sign up to see email
-
Dr Darius Francescatti
Medical Advisory Board
-
z40451@92q9yf681.wr.j5 Sign up to see email
-
xxf2b@b01157hh4.hl.hp Sign up to see email
-
fj9602z@zqpw75f66.b8.73 Sign up to see email
-
Peter Balmforth
Non-Executive Director
-
Prof Carlo Palmieri
Medical Advisory Board
-
Prof Chris Philips
Scientific Advisory Board
-
vv41v8j.454@e17678ph8.hh.29 Sign up to see email
-
0f97qpq9@2xjr84qbv.7b.7e Sign up to see email
Digistain Company Information
Founded at Imperial College London and part of the Y-Combinator S21 batch, Digistain is headquartered in Newport Pagnell, United Kingdom. The company, employing a team of 40, operates primarily in the healthcare industry, focusing on diagnostics. Digistain has developed a proprietary technology that utilizes existing hospital equipment to analyze patient samples in-house. This technology, enhanced by an innovative algorithm, identifies a unique spectral fingerprint of breast tumors in the infrared spectrum and provides a personalized risk score. This score aids oncologists in devising effective, individualized treatment plans. Digistain’s technology has shown clinical evidence that matches the market leader’s performance but is more cost-effective and faster, as demonstrated in a government-commissioned study. The technology is also supported by insurance reimbursement at leading cancer centers. Recognized for its contributions by the Institute of Physics, the Royal Society, and Imperial College, and supported by the NHS, Y Combinator, and the European Investment Bank, Digistain’s mission is to eliminate breast cancer care inequalities by transforming the speed, cost, and accuracy of recurrence risk prediction. The company’s approach not only aims to accelerate informed treatment decision-making but also seeks to advance overall cancer patient outcomes by eliminating the subjectivity inherent in traditional biomarker analysis.
Report inaccurate information
Report inaccurate information
